Ghanekar Yashoda, Chandrashaker Akhila, Tatu Utpal, Visweswariah Sandhya S
Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India.
Biochem J. 2004 May 1;379(Pt 3):653-63. doi: 10.1042/BJ20040001.
GC-C (guanylate cyclase C) is the receptor for heat-stable enterotoxins, guanylin and uroguanylin peptides. Ligand binding to the extracellular domain of GC-C activates the guanylate cyclase domain leading to accumulation of cGMP. GC-C is expressed as differentially glycosylated forms in HEK-293 cells (human embryonic kidney-293 cells). In the present study, we show that the 145 kDa form of GC-C contains sialic acid and galactose residues and is present on the PM (plasma membrane) of cells, whereas the 130 kDa form is a high mannose form that is resident in the endoplasmic reticulum and serves as the precursor for the PM-associated form. Ligand-binding affinities of the differentially glycosylated forms are similar, indicating that glycosylation of GC-C does not play a role in direct ligand interaction. However, ligand-stimulated guanylate cyclase activity was observed only for the fully mature form of the receptor present on the PM, suggesting that glycosylation had a role to play in imparting a conformation to the receptor that allows ligand stimulation. Treatment of cells at 20 degrees C led to intracellular accumulation of a mature glycosylated form of GC-C that now showed ligand-stimulated guanylate cyclase activity, indicating that localization of GC-C was not critical for its catalytic activity. To determine if complex glycosylation was required for ligand-stimulated activation of GC-C, the receptor was expressed in HEK-293 cells that were deficient in N -acetylglucosaminyltransferase 1. This minimally glycosylated form of the receptor was expressed on the cell surface and could bind a ligand with an affinity comparable with the 145 kDa form of the receptor. However, this form of the receptor was poorly activated by the ligand. Therefore our studies indicate a novel role for glycosidic modification of GC-C during its biosynthesis, in imparting subtle conformational changes in the receptor that allow for ligand-mediated activation and perhaps regulation of basal activity.
鸟苷酸环化酶C(GC-C)是热稳定肠毒素、鸟苷蛋白和尿鸟苷蛋白肽的受体。配体与GC-C的细胞外结构域结合会激活鸟苷酸环化酶结构域,导致环磷酸鸟苷(cGMP)积累。GC-C在人胚肾293细胞(HEK-293细胞)中以不同糖基化形式表达。在本研究中,我们发现145 kDa形式的GC-C含有唾液酸和半乳糖残基,存在于细胞的质膜(PM)上,而130 kDa形式是一种高甘露糖形式,驻留在内质网中,是质膜相关形式的前体。不同糖基化形式的配体结合亲和力相似,表明GC-C的糖基化在直接配体相互作用中不起作用。然而,仅在质膜上存在的受体的完全成熟形式观察到配体刺激的鸟苷酸环化酶活性,这表明糖基化在赋予受体一种允许配体刺激的构象中发挥作用。在20℃处理细胞导致成熟糖基化形式的GC-C在细胞内积累,现在显示出配体刺激的鸟苷酸环化酶活性,这表明GC-C的定位对其催化活性并不关键。为了确定配体刺激的GC-C激活是否需要复杂糖基化,该受体在缺乏N-乙酰葡糖胺转移酶1的HEK-293细胞中表达。这种受体的最小糖基化形式在细胞表面表达,并且能够以与145 kDa形式的受体相当的亲和力结合配体。然而,这种形式的受体被配体激活的程度很差。因此,我们的研究表明GC-C在其生物合成过程中的糖苷修饰具有新作用,即赋予受体微妙的构象变化,从而允许配体介导的激活以及可能对基础活性的调节。